List view / Grid view
Blockchain technologies have the potential to improve transparency, efficiency and reliability of transactions in a heavily regulated pharmaceutical industry. However, there are challenges and limitations. Nikki Withers speaks to Bob Celeste, founder of the Centre for Supply Chain Studies, who has been exploring the potential use of blockchain technology to…
Simplify your artwork process, get closer to your customers and strengthen compliance...
The pilot project will test innovative and emerging approaches for enhanced tracing and verification of prescription drugs in the US...
Service expansion in Brazil will meet transportation demands of the pharmaceutical and clinical research industry...
The evolution of antibody-drug conjugates (ADCs) is a spectacular example of how global research can sculpt a new technology. Years of molecular and cell biology, conjugation chemistry and immunology progress has enabled a cytotoxic agent paired with a tumour-specifi c antibody to become mainstream cancer therapy.1 Today, advances continue, explains…
microPHAZIR RX handheld analyzer is used by pharmaceutical manufacturers for GMP compliant incoming raw material identification, quality control and assurance, and at-line PAT.
On 23 June 2016, the decision was made on the European Union referendum for the United Kingdom to withdraw from the European Union.
Systech is the global technology leader in supply chain security and product authentication. For more than 30 years, we have put technology on the line...
North America dominates the global market for pharmaceutical glass packaging, due to the region’s technical innovation and strong demand for pharmaceutical products...
The EMA has revised downwards the number of medicines expected to face Brexit-related supply disruptions from 108, earlier this year, to a current level of 39...
18 September 2018 | By Clarivate Analytics
In 2017 the WHO estimated that the counterfeit drug market represents around 10-15 percent of the pharmaceutical market worldwide, with an estimated $200bn revenue per year. Worldwide there were 3,509 pharmaceutical crime incidents in 2017, which represents an 11% increase from 2016. Most falsified medicines that reach the market do…
The global pharmaceutical industry has been expanding steadily at varying rates of regional growth; the pace of growth being relatively slow in the developed, matured markets but rapid in developing nations...
The FDA is seeking closer collaboration with state authorities to ensure the quality of compounded drugs and the public’s access to them...
A new project led by the Karolinska Institutet in Sweden aims to improve the standards of drug safety in East Africa...
A Europe-wide policy covering the generic pharmaceuticals market would significantly boost growth in the sector, reveals a new report from Frost & Sullivan...
